Instructions for Cytovir-3
Description Cytovir-3:
Cytovir-3 is used to reduce the risk of infection and to treat viral diseases. It is an immunomodulatory antiviral agent. Can be used to treat adults and children. The active ingredients of the drug are active against influenza viruses and other pathogens that cause ARVI.
A course of drug therapy helps to significantly reduce the risk of disease. If the patient is already infected, the remedy is used to relieve symptoms and speed up recovery.
The drug contains three active ingredients.
Bendazole hydrochloride is responsible for major medicinal effects associated with improving the immune system. Glutamyl-tryptophan dipeptide performs auxiliary immunostimulating functions. Ascorbic acid is required by the body to protect and repair tissues. The individual components of this combination product enhance the overall therapeutic effect.
Structure:
Per capsule Cytovir-3:
Active substances:
sodium alpha-glutamyl-tryptophan (Thymogen sodium) 0.5 mg, ascorbic acid 50 mg, bendazole hydrochloride (Dibazol) 20 mg;
Excipients Cytovir-3:
Lactose monohydrate 97.8 mg, calcium stearate 1.7 mg;
Shell composition: body: titanium dioxide 2%, gelatin up to 100%. Cap: titanium dioxide 2%, dye sunset yellow 0.2190%, dye azorubin 0.0328, gelatin up to 100%.
Indications for use Cytovir-3:
- Prevention and complex therapy of influenza and acute respiratory viral infections in adults and children over 6 years old.
Pharmacokinetics Cytovir-3:
When taken orally, the drug is completely absorbed from the gastrointestinal tract. Bioavailability of bendazole is about 80%, alpha-glutamyl-tryptophan is no more than 15%, ascorbic acid is up to 90%. The metabolites of ascorbic acid and
bendazole are excreted in the urine. Alpha-glutamyl-tryptophan is cleaved by peptidases into L-glutamic acid and L-tryptophan, which are used by the body in peptide synthesis.
Pharmacodynamics Cytovir-3:
The drug Cytovir-3 is a means of etiotropic and immunostimulating therapy, has an indirect antiviral effect against influenza A and B pathogens, as well as other viruses that cause acute respiratory diseases.
Reduces the severity of the main clinical symptoms of influenza and acute respiratory viral infections, and also reduces the duration of the disease and contributes to its uncomplicated course.
Increases the content of secretory immunoglobulin A (slgA) in the mucous membrane of the nasopharynx - the entrance gate of infection, increasing the body's local immunoresistance to respiratory infections of viral and bacterial nature.
With a prophylactic action, the drug increases the potential metabolic activity of cells of innate immunity (neutrophilic granulocytes and monocytes), which, in the event of an infection, increases their ability to absorb and destroy bacterial and viral agents by increasing enzymatic (oxidative) activity, synthesis of cationic proteins and increasing the number of phagocytic cells. In this case, the initial state of metabolic activity of cells of innate immunity, in the absence of infectious agents, does not change, being within normal values.
Bendazol induces the production of endogenous interferon in the body, has an immunomodulatory effect (normalizes the body's immune response to various infectious agents). Enzymes, the production of which is induced by interferon in
cells of various organs, inhibit viral replication. Alpha-glutamyl-tryptophan (thymogen) is a synergist of the immunomodulatory action of bendazole, normalizing the T-cell link of immunity. Cytovir-3
Ascorbic acid activates the humoral link of immunity, normalizes capillary permeability, thereby reducing inflammation, exhibits antioxidant properties, neutralizing oxygen radicals accompanying the inflammatory process, and
increases the body's resistance to infection.
Contraindications Cytovir-3:
Hypersensitivity to the components of the drug, pregnancy, children under 6 years of age.
With caution:
during breastfeeding, use is possible if the intended benefit to the mother outweighs the potential risk to the child.
Side effects Cytovir-3:
Allergic reactions, short-term decrease in blood pressure.
Method of preparation or use Cytovir-3:
Inside, 30 minutes before meals. Single dose for adults and children over 6 years of age -1 capsule.
For treatment: one capsule 3 times a day for 4 days. For prophylaxis: - in direct contact with a patient with influenza and other acute respiratory viral infections, one capsule 3 times a day for 4 days.
during an epidemic rise in the incidence of influenza and other acute respiratory viral infections, one capsule 1 time per day for 12 days.
Preventive courses, if necessary, are repeated after 3 weeks (until the epidemic situation returns to normal).
